Table 2.
Variables | Cases (n=141) |
Overall survival time (months)
|
P-value# | |
---|---|---|---|---|
Mean | Median | |||
Age (years) | 0.004* | |||
≤60 | 103 | 83.07 | 82 | |
>60 | 38 | 57.09 | 60 | |
FIGO stage | 0.020* | |||
I–II | 46 | 91.68 | 88 | |
III–IV | 95 | 68.96 | 68 | |
Histology type | 0.483 | |||
Serous | 121 | 74.90 | 72 | |
Non-serous | 20 | 84.09 | 82 | |
Pathological grade | 0.037* | |||
G1–G2 | 97 | 81.80 | 81 | |
G3 | 44 | 64.89 | 60 | |
Lymph node metastasis | 0.005* | |||
No | 64 | 89.45 | 83 | |
Yes | 77 | 64.48 | 66 | |
Preoperative CA-125 (U/mL) | 0.795 | |||
≤900 | 73 | 78.20 | 82 | |
>900 | 68 | 74.89 | 72 | |
USP7 expression | 0.003* | |||
Low expression | 82 | 85.75 | 83 | |
High expression | 59 | 62.34 | 60 |
Notes:
Log-rank correlation test.
Statistically significant.
Abbreviations: USP7, ubiquitin-specific protease 7; EOC, epithelial ovarian cancer; FIGO, International Federation of Gynecology and Obstetrics; CA, cancer antigen.